Oral ibuprofen is superior to oral paracetamol for patent ductus arteriosus in very low and extremely low birth weight infants
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference47 articles.
1. Assciation betweeen platelet counts before and during pharmacological therapy for patent ductus arterious and treatment failure in preterm infants;Sallmon;Front Pediatr,2018
2. Association between furosemide exposure and patent ductus arteriosus in hospitalized infants of very low birth weight;Thompson;J Pediatr,2018
3. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates;El-Mashad;Eur J Pediatr,2017
4. Neurodevelopmental outcomes of preterm infants treated with oral paracetamol versus ibuprofen for patent ductus arteriosus;Oncel;Am J Perinatol,2017
5. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: A randomised controlled trial;Lago;Eur J Pediatr,2002
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pharmacokinetic and Pharmacodynamic Analysis of Acetaminophen and Ibuprofen Dual Therapy for Patent Ductus Arteriosus Closure in Preterm Neonates at Less Than 29 Weeks of Gestation;The Journal of Clinical Pharmacology;2023-12-14
2. Risk stratification of hemodynamically significant patent ductus arteriosus by clinical and genetic factors;World Journal of Pediatrics;2023-06-15
3. Different approaches for patent ductus arteriosus in premature infants using acetaminophen;World Journal of Pediatrics;2022-03-06
4. Qual Deve Ser o Tratamento de Primeira Linha para o Fechamento de Persistência de Canal Arterial Hemodinamicamente Significativo em Bebês Prematuros?;Arquivos Brasileiros de Cardiologia;2021-12-08
5. Platelet Count Might Be Associated With the Closure of Hemodynamically Significant Patent Ductus Arteriosus;Frontiers in Pediatrics;2021-10-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3